US 7919594
Human anti-CD100 antibodies
granted A61KA61K2039/505A61P
Quick answer
US patent 7919594 (Human anti-CD100 antibodies) held by VACCINEX, INC. expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VACCINEX, INC.
- Grant date
- Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00, A61P37/06